CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 156 filers reported holding CLOVIS ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 1.84 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $446,000 | -19.9% | 4,763 | -24.8% | 0.01% | -33.3% |
Q2 2015 | $557,000 | -24.5% | 6,335 | -51.9% | 0.01% | -10.0% |
Q4 2014 | $738,000 | +23.4% | 13,179 | 0.0% | 0.01% | +11.1% |
Q3 2014 | $598,000 | +9.5% | 13,179 | 0.0% | 0.01% | +12.5% |
Q2 2014 | $546,000 | -24.5% | 13,179 | +22.1% | 0.01% | -27.3% |
Q2 2013 | $723,000 | – | 10,796 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |